ArticleJournal of experimental & clinical cancer research : CR2017

Rapamycin (mTORC1 inhibitor) reduces the production of lactate and 2-hydroxyglutarate oncometabolites in IDH1 mutant fibrosarcoma cells.

Zoltán Hujber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.